0001127602-16-044957.txt : 20160303
0001127602-16-044957.hdr.sgml : 20160303
20160303200014
ACCESSION NUMBER: 0001127602-16-044957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160301
FILED AS OF DATE: 20160303
DATE AS OF CHANGE: 20160303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36172
FILM NUMBER: 161483299
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-01
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242992
CLACKSON TIMOTHY P
C/O ARIAD PHARMACEUTICALS INC
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
President, R&D, CSO
Common Stock
2016-03-01
4
M
0
19250
0
A
369302
D
Common Stock
2016-03-02
4
S
0
25047
6.00
D
344255
D
Common Stock
2016-03-03
4
S
0
9625
6.1161
D
334630
D
Performance stock unit
2016-03-01
4
M
0
19250
0
D
Common Stock
19250
19250
D
Performance stock unit
2016-03-01
4
A
0
38500
0
A
Common Stock
38500
38500
D
Shares were acquired upon vesting of performance stock units awarded on January 31, 2014.
Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.04 to $6.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Each performance stock unit represents a right to receive one share of ARIAD common stock.
The performance stock units vest as to 50% of the award on 3/1/2016 and 50% of the award on 3/1/2017.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2016-03-03